Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMMT98V)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Phospholipase D1 (PLD1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
US9453017, 1	DMVQ3IX	N. A.	N. A.	Patented	[2]
US9127005, P2B	DM3R7BT	N. A.	N. A.	Patented	[1]
ML272	DMNEY58	N. A.	N. A.	Patented	[2]
US9127005, P0L	DMKLYCV	N. A.	N. A.	Patented	[1]
US9453017, 2	DMPH05Y	N. A.	N. A.	Patented	[2]
1-(pyridin-2-yl)piperazine	DMKE7FG	Discovery agent	N.A.	Investigative	[3]
HALOPEMIDE	DMF6V8W	Discovery agent	N.A.	Investigative	[4]
1-(pyridin-4-yl)piperazine	DM78AJ1	Discovery agent	N.A.	Investigative	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Isoform selective phospholipase D inhibitors. US9127005.
2	Antiviral therapies with phospholipase D inhibitors. US9453017.
3	Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privil... Bioorg Med Chem Lett. 2009 Apr 15;19(8):2240-3.
4	Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol. 2009 Feb;5(2):108-17.